Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with ...

Vuzix Corporation (NASDAQ:VUZI) is one of the 12 best-augmented reality stocks to buy, according to analysts. On June 24, ...

PTC Inc. (NASDAQ:PTC) is one of the 12 best-augmented reality stocks to buy, according to analysts. On June 12, the company ...